Physician profile
Hui Zhang
NPI 1134581200
$25,077.41
in general payments reported to CMS, 2019-2025
15 companies · $1,010 in 2025
The $1,010 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $1,337 · 2021: $13K · 2022: $9,375 · 2023: $13.10 · 2024: $23.81 · 2025: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $246.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,940.99 | 2020-2022 | |
| Stryker Corporation | $3,527.15 | 2019-2025 | Inbone, Infinity Adaptis, Citrefix |
| Gemini Medical LLC | $1,200.00 | 2021 | |
| Enduromed, LLC | $1,200.00 | 2022 | |
| Trimed, INC. | $915.06 | 2021-2025 | |
| Fusion Orthopedics USA, LLC | $846.56 | 2024-2025 | Pilon Plates |
| Paragon 28, INC. | $813.62 | 2021-2022 | |
| Medacta USA, INC. | $158.78 | 2021 | |
| Nuvasive, INC. | $118.88 | 2019-2020 | |
| Kci USA, INC. | $110.42 | 2022 | |
| Great Lakes Orthopedics | $105.54 | 2022 | |
| Smith+Nephew, INC. | $96.60 | 2021 | |
| Depuy Synthes Sales INC. | $18.61 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.10 | 2023 | Invega Sustenna |
| Exactech, INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hui Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.